866-997-4948(US-Canada Toll Free)

Atopic Dermatitis - Pipeline Assessment and Market Forecasts to 2017

Published By :

GlobalData

Published Date : Sep 2010

Category :

Therapeutic Area

No. of Pages : 38 Pages


GlobalData has released its pharmaceutical report, Atopic Dermatitis Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Atopic Dermatitis therapeutics market. The report identifies the key trends shaping and driving the global Atopic Dermatitis therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global Atopic Dermatitis sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts. 

GlobalData has estimated the global atopic dermatitis therapeutics market to be valued at $728m in 2009. It is expected to grow to $942m at a Compound Annual Growth Rate (CAGR) of 3.3% by 2017. This growth is primarily attributed to an increase in competition among existing products and the presence of a strong pipeline with more emerging therapies. Globally, the US remains the largest market for atopic dermatitis therapeutics, and was valued at $415m in 2009.However, with most of the demand expected to come from the developed economies, the center of global atopic dermatitis therapeutics market activity is potentially due for a paradigm shift. 

Scope

The scope of the report includes: 

  • Annualized global Atopic Dermatitis therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017. 
  • Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.
  • Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include Anti-inflammatory, Corticosteroid, Interleukin Inhibitor, Antimicrobial, Immunomodulators, Protease Inhibitor, Nuclear Factor-Kappa B (NF-kB) inhibitor, Selective cannabinoid 2 receptor agonist, T-cell inhibitor, Vitamin D derivative, Cytokine Modulator, NO synthase inhibitor, Kinase Inhibitor,Calcineurin Inhibitor, Anti-pruritic, Histamine H1 antagonist, Chymase inhibitor, Anti-Neoplastic, TNF Antagonist, Non-steroid, Anti-itching, Vaccine, Combination, H4R antagonist, Serine proteinase inhibitor, RAFT modulator, Neurokinin 1 (NK1) receptor agonists, Vascular adhesion protein-1 (VAP-1) inhibitor, non-comedogenic, Fibroblast Growth Factor (FGF) inhibitor, TSLP interaction Inhibitor, Phosphodiesterase 4 (PDE4) Inhibitor, NGF receptor blocker and Glucocorticoid receptor agonist.
  • Analysis of the current and future market competition in the global Atopic Dermatitis therapeutics market. The key future market players covered are Provectus Pharmaceuticals, AnGes MG Inc., Creabilis Therapeutics, Asubio Pharma, Almirall, Anacor Pharma, MIKA Pharma GmbH, Shionogi USA, Inc. and Serentis Ltd
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. 
  • Key topics covered include a strategic competitor assessment, a market characterization, the unmet needs and the implications for the Atopic Dermatitis market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipelines.
  • Develop business strategies by understanding the trends shaping and driving the global Atopic Dermatitis therapeutics market. 
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to affect the global Atopic Dermatitis therapeutics market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. 
  • Identify the emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investments and strategic partnerships.
  • Whats the next big thing in the global Atopic Dermatitis therapeutics market landscape? Identify, understand and capitalize.
Table Of Contents

1 Table of contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Atopic Dermatitis Therapeutics Market: Introduction 4
2.1 GlobalData Pipeline Report Guidance 4

3 Atopic Dermatitis Therapeutics Market: Market Characterization 5
3.1 Atopic Dermatitis Therapeutics Market Size 5
3.2 Atopic Dermatitis Therapeutics Market Forecast and CAGR 6
3.3 Drivers and Barriers for the Atopic Dermatitis Therapeutics Market 7
3.3.1 Drivers for the Atopic Dermatitis Therapeutics Market 7
3.3.2 Barriers for the Atopic Dermatitis Therapeutics Market 7
3.4 Opportunity and Unmet Need 9
3.5 Key Takeaway 10

4 Atopic Dermatitis Therapeutics Market: Competitive Assessment 11
4.1 Overview 11
4.2 Strategic Competitor Assessment 11
4.3 Product Profile for the Major Marketed Products in the Atopic Dermatitis Therapeutics Market 12
4.3.1 Protopic (Tacrolimus) 12
4.3.2 Elidel (Pimecrolimus) 13
4.3.3 MimyX 15
4.3.4 Atopiclair 15
4.3.5 Topical Corticosteroids 16
4.4 Key Takeaway 17

5 Atopic Dermatitis Therapeutics Market: Pipeline Assessment 18
5.1 Overview 18
5.2 Strategic Pipeline Assessment 18
5.2.1 Technology Trends Analytical Framework 18
5.3 Atopic Dermatitis Therapeutics Promising Drugs under Clinical Development 19
5.4 List of Promising Products under Clinical Development 20
5.5 Molecule Profile for Promising Drugs under Clinical Development 21
5.5.1 PH-10 21
5.5.2 NF

List of Table


Table 1: Atopic Dermatitis Therapeutics Market, Global, Revenues ($m), 20012009 5
Table 2: Atopic Dermatitis Therapeutics Market, Global, Market Forecast ($m), 2009-2017 6
Table 3: Atopic Dermatitis Therapeutics Market, Global, Key Examples of Clinical Studies Conducted on Herbal Products, 2010 8
Table 4: Atopic Dermatitis Therapeutics Market, Global, Comparative Study on the Efficacy of Protopic in Phase III Clinical Trials, 2003 13
Table 5: Atopic Dermatitis Therapeutics Market, Global , Comparative Study on the Efficacy of Elidel in Clinical Trials, 1998-2002 14
Table 6: Atopic Dermatitis Therapeutics Market, Global, Major Marketed Products Comparison, 2010 17
Table 7: Atopic Dermatitis Therapeutics Most Promising Drugs Under Clinical Development, 2010 19
Table 8: Atopic Dermatitis Therapeutics Promising Drugs Under Clinical Development, 2010 20
Table 9: Atopic Dermatitis Therapeutics Phase III Clinical Pipeline, 2010 24
Table 10: Atopic Dermatitis Therapeutics Phase II Clinical Pipeline, 2010 25
Table 11: Atopic Dermatitis Therapeutics Phase I Clinical Pipeline, 2010 26
Table 12: Atopic Dermatitis Therapeutics Pre-Clinical and Discovery Pipeline, 2010 27
Table 13: Provectus Pharmaceuticals Dermatology Pipeline Products, 2010 30
Table 14: AnGes MG Inc. Dermatology Pipeline Products, 2010 30
Table 15: Creabilis Therapeutics Dermatology Pipeline Products, 2010 31
Table 16: Serentis Ltd. Dermatology Pipeline Products, 2010 31

List of Chart


Figure 1: Atopic Dermatitis Therapeutics Market, Global, Revenues ($m), 20012009 5
Figure 2: Atopic Dermatitis Therapeutics Market, Global, Market Forecast ($m), 2009-2017 6
Figure 3: Opportunity and Unmet Need in the Atopic Dermatitis Therapeutics Market, 2010 9
Figure 4: Strategic Competitor Assessment of the Major Marketed Products in Atopic Dermatitis Therapeutics, 2010 11
Figure 5: Technology Trends Analytic Framework of the Atopic Dermatitis Therapeutics Pipeline, 2010 18
Figure 6: Technology Trends Analytic Framework of the Atopic Dermatitis Therapeutics Pipeline Description, 2010 19
Figure 7: Atopic Dermatitis Therapeutics Market Clinical Pipeline by Mechanism of Action, 2010 23
Figure 8: Atopic Dermatitis Therapeutics Pipeline by Phase of Clinical Development, 2010 24
Figure 9: Implications for Future Market Competition in the Atopic Dermatitis Therapeutics Market, 2010 28
Figure 10: Atopic Dermatitis Therapeutics Market Clinical Pipeline by Company, 2010 29
Figure 11: GlobalData Market Forecasting Model 36

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *